PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC
Clinical trial NCT04809779 · UNKNOWN
Trial details
- NCT number
- NCT04809779
- Sponsor
- First Affiliated Hospital, Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.